JP2024542021A5 - - Google Patents
Info
- Publication number
- JP2024542021A5 JP2024542021A5 JP2024525628A JP2024525628A JP2024542021A5 JP 2024542021 A5 JP2024542021 A5 JP 2024542021A5 JP 2024525628 A JP2024525628 A JP 2024525628A JP 2024525628 A JP2024525628 A JP 2024525628A JP 2024542021 A5 JP2024542021 A5 JP 2024542021A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163273785P | 2021-10-29 | 2021-10-29 | |
| US202163273792P | 2021-10-29 | 2021-10-29 | |
| US63/273,792 | 2021-10-29 | ||
| US63/273,785 | 2021-10-29 | ||
| US202263315482P | 2022-03-01 | 2022-03-01 | |
| US63/315,482 | 2022-03-01 | ||
| US202263391136P | 2022-07-21 | 2022-07-21 | |
| US63/391,136 | 2022-07-21 | ||
| PCT/US2022/078995 WO2023077129A1 (en) | 2021-10-29 | 2022-10-31 | Tetrazine conjugates for in vivo targeted delivery of a payload |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2024542021A JP2024542021A (ja) | 2024-11-13 |
| JPWO2023077129A5 JPWO2023077129A5 (https=) | 2025-11-11 |
| JP2024542021A5 true JP2024542021A5 (https=) | 2025-11-11 |
Family
ID=84362765
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024525628A Pending JP2024542021A (ja) | 2021-10-29 | 2022-10-31 | ペイロードのｉｎ ｖｉｖｏ標的化送達用のテトラジンコンジュゲート |
Country Status (4)
| Country | Link |
|---|---|
| US (1) | US20250186592A1 (https=) |
| EP (1) | EP4422696A1 (https=) |
| JP (1) | JP2024542021A (https=) |
| WO (1) | WO2023077129A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4669357A1 (en) * | 2023-02-21 | 2025-12-31 | Tambo, Inc. | TRANS-CYCLOOCTENE CONJUGATES |
| AU2024300552A1 (en) * | 2023-07-27 | 2026-01-29 | Veraxa Biotech Gmbh | Hydrophilic trans-cyclooctene (hytco) compounds, constructs and conjugates containing the same |
| WO2025059685A1 (en) * | 2023-09-15 | 2025-03-20 | Tambo, Inc. | Methods for in vivo targeted delivery of a payload |
| WO2025260150A1 (en) * | 2024-06-21 | 2025-12-26 | Microbiológica Química E Farmacêutica Ltda. | Novel n-benzyl phthalimides for the treatment of pain. methods of preparation and therapeutic use |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR104E (https=) | ||||
| EE200300089A (et) | 2000-09-08 | 2005-02-15 | Gryphon Therapeutics, Inc. | Sünteetilised erütropoeesi stimuleerivad valgud, nende valmistamismeetodid ning kasutamine |
| US10130711B2 (en) | 2013-06-19 | 2018-11-20 | The Regents Of The University Of California | Chemical structures for localized delivery of therapeutic agents |
| ES2880468T3 (es) | 2014-03-14 | 2021-11-24 | Univ California | Conjugados de TCO y métodos para el suministro de agentes terapéuticos |
| JP6823067B2 (ja) | 2015-09-10 | 2021-01-27 | タンボ・インコーポレイテッド | 生体直交型組成物 |
| WO2017106427A1 (en) * | 2015-12-15 | 2017-06-22 | Joseph Fox | Methods for inducing bioorthogonal reactivity |
| ES2983582T3 (es) | 2017-04-07 | 2024-10-23 | Tambo Inc | Composiciones bioortogonales |
| IL282114B2 (en) | 2018-10-10 | 2025-05-01 | Tambo Inc | Processes for preparing functional cyclooctanes |
| AU2020310853A1 (en) | 2019-07-05 | 2022-01-27 | Tambo, Inc. | Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy |
| EP4295917A3 (en) | 2020-08-07 | 2024-02-28 | Tambo, Inc. | Trans-cyclooctene bioorthogonal agents and uses in cancer and immunotherapy |
-
2022
- 2022-10-31 JP JP2024525628A patent/JP2024542021A/ja active Pending
- 2022-10-31 US US18/705,504 patent/US20250186592A1/en active Pending
- 2022-10-31 WO PCT/US2022/078995 patent/WO2023077129A1/en not_active Ceased
- 2022-10-31 EP EP22813075.3A patent/EP4422696A1/en active Pending